Autism is a devastating neuropsychiatric condition with unknown pathophysiology. Autism spectrum disorders (ASD) have an estimated incidence of 1/200 and thus are more common than many other childhood disorders. Although ASD have a multifactorial etiology, it has a large genetic component. It is also becoming clear that comprehensive efforts involving large sample sizes and methods to reduce heterogeneity are necessary to achieve maximal power to identify disease critical regions narrow enough to permit positional cloning of autism susceptibility genes. The investigators in this application aim to continue their collaborative effort that has produced and enhanced a highly successful open data and biomaterials resource for the research community, the Autism Genetic Resource Exchange (AGRE). This collaborative network application involving six research sites and the AGRE DCC, will systematically and comprehensively investigate the genetics of ASD to identify rare mutations, chromosomal abnormalities, and common variation contributing to ASD susceptibility. Specifically, they will enrich existing resources by adding 400 simplex families, including 200 families of African American descent, in addition to phenotype enrichment. The large overall sample size permits stratification of families based on analysis of heritable quantitative and qualitative endophenotypes. It further allows independent confirmation of loci as demonstrated for chromosome 17 and provides adequate sample for whole genome association studies to find loci with adequate power. The investigators will perform follow up linkage studies to confirm several new loci identified based on autism-related endophenotypes or co- variants, such as language delay, sex, and head circumference. In parallel, comparative genomic hybridization (CGH) using 500k SNP arrays will be performed, yielding the highest resolution molecular karyotypes and providing a resource on genome wide copy number variation (CNV) in ASD. CNV identified will be followed in family members and controls using QPCR and FISH. The use of SNP genotyping for CNV detection in ASD probands further provides for significant economies, since additional genotyping need only be conducted in the parents for efficient whole genome association studies. Regions or genes identified by linkage will be followed up by efficient, staged dense SNP genotyping. CNV assessment and WGA will also yield candidates that will be integrated with the linkage results for focused confirmatory studies, including re-sequencing to identify and confirm potentially causal genetic variants. Genetic risk factors identified in the mostly white European sample will be tested for association in the African American sample to determine whether these cohorts share the same genetic risk factors. All phenotypic and genotype data will be made accessible via the Internet on a rolling basis, including minority families, further enhancing the value of this resource to the community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH081754-05
Application #
8228107
Study Section
Special Emphasis Panel (ZHD1-MRG-C (04))
Program Officer
Addington, Anjene M
Project Start
2008-04-01
Project End
2013-03-24
Budget Start
2012-02-01
Budget End
2013-03-24
Support Year
5
Fiscal Year
2012
Total Cost
$2,631,440
Indirect Cost
$469,659
Name
University of California Los Angeles
Department
None
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Gaugler, Trent; Klei, Lambertus; Sanders, Stephan J et al. (2014) Most genetic risk for autism resides with common variation. Nat Genet 46:881-5
Kim, Young Shin; State, Matthew W (2014) Recent challenges to the psychiatric diagnostic nosology: a focus on the genetics and genomics of neurodevelopmental disorders. Int J Epidemiol 43:465-75
Gupta, Simone; Ellis, Shannon E; Ashar, Foram N et al. (2014) Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat Commun 5:5748
Krystal, John H; State, Matthew W (2014) Psychiatric disorders: diagnosis to therapy. Cell 157:201-14
Lu, A T-H; Yoon, J; Geschwind, D H et al. (2013) QTL replication and targeted association highlight the nerve growth factor gene for nonverbal communication deficits in autism spectrum disorders. Mol Psychiatry 18:226-35
Sampath, Srirangan; Bhat, Shambu; Gupta, Simone et al. (2013) Defining the contribution of CNTNAP2 to autism susceptibility. PLoS One 8:e77906
Stein, Jason L; Parikshak, Neelroop N; Geschwind, Daniel H (2013) Rare inherited variation in autism: beginning to see the forest and a few trees. Neuron 77:209-11
Voineagu, Irina (2012) Gene expression studies in autism: moving from the genome to the transcriptome and beyond. Neurobiol Dis 45:69-75
Voineagu, I; Huang, L; Winden, K et al. (2012) CCDC22: a novel candidate gene for syndromic X-linked intellectual disability. Mol Psychiatry 17:4-7
Konopka, G; Wexler, E; Rosen, E et al. (2012) Modeling the functional genomics of autism using human neurons. Mol Psychiatry 17:202-14

Showing the most recent 10 out of 33 publications